IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Checkpoint Capital L.P.

Q2 2024 Holdings

Filed 2024-08-14 | 16 holdings | $165.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$37.9M922,10022.8%
Argenx SE(ARGX)SPONSORED ADR04016X101$35.3M82,15021.3%
Axsome Therapeutics Inc(AXSM)COM05464T104$23.4M290,77214.1%
Avadel Pharmaceuticals PLCCOM SHSG29687103$16.0M1,138,1789.6%
Protagonist Therapeutics Inc(PTGX)COM74366E102$12.3M355,0007.4%
Cytokinetics Inc(CYTK)COM NEW23282W605$10.3M190,0006.2%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$9.0M875,0005.4%
Corcept Therapeutics Inc(CORT)COM218352102$8.0M244,7504.8%
Atyr Pharma Inc(ATYR)COM NEW002120202$3.0M1,946,4771.8%
Pliant Therapeutics Inc(PLRX)COM729139105$2.5M232,2001.5%
Kymera Therapeutics Inc(KYMR)COM501575104$2.4M82,0001.5%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$1.7M145,4171.0%
Trevi Therapeutics Inc(TRVI)COM89532M101$1.5M500,0890.9%
Applied Therapeutics Inc(APLT)COM03828A101$1.1M227,4700.6%
Soleno Therapeutics Inc(SLNO)COM834203309$803.6K19,6950.5%
Allakos Inc(ALLKGUSD)COM01671P100$650.0K649,9570.4%